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ABSTRACT: Nuc!eolar organizer regions (Ag-NORs) were studied in patients with cervical precancer- 
ous and cancerous lesions along with controls. The data revealed a statistically significant 
decrease of Ag-NORs in cancer patients, as well as in women with severe precancerous le- 
sions as compared with controls. A similar decrease in the amount of Ag-staining was also 
observed in both cancer and severe dysplasia cases. The study suggests a possible relation- 
ship of Ag-NOR activity to malignancy. 
INTRODUCTION 
Nucleolar organizer egions (NOR) in humans are visual ized as secondary constric- 
tion regions of acrocentric hromosomes of D and G groups by silver staining meth- 
ods [1, 2]. Hybridization techniques in situ demonstrated that NORs contain the 
RNA genes for 18s and 28s [3, 4], and somatic cell hybridizat ion techniques further 
demonstrated that the active NOR8 are preferential ly stained by the silver staining 
method [5, 6]. The frequency of Ag-NOR was found to be fairly constant in a partic- 
ular tissue of an individual,  although variations also have been reported in different 
tissues [7-10]. Reports on NOR activity in malignant diseases are contradictory. 
Some malignant diseases, such as lymphoma, leukemia, and solid tumors, showed 
fewer or similar number of Ag-NORs to those of healthy individuals [11-13]. On 
the other hand, an increased frequency of Ag-NORs was reported in the leukocytes 
of female patients with adenocarcinoma [14] and in hypodip lo id tumor cells of 
meningiomas [15]. In the present communicat ion we report the frequency of Ag- 
NORs in the leukocytes of female patients with cervical precancerous and cancer- 
ous lesions. 
MATERIALS AND METHODS 
Fifty-three women with cervical precancerous lesions (dysplasias), 16 cervical can- 
cer patients, and 37 healthy women were included in the study. The ages of the 
three groups were more or less matched. The ages for the controls, precancerous, 
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and cancerous groups were 23-65, 22-62, and 22-60 years, respectively. Patients 
were diagnosed cytomorphological ly according to WHO criteria [16]. 
Of the 53 cases of precancerous lesions, 23, 22, and 8 were from mild, moderate, 
and severe dysplasias, respectively. Cancer patients and some of the patients having 
precancerous lesions were diagnosed both cytologically and histopathologically. 
Whole blood was cultured in TC 199 medium supplemented with 20% heat inacti- 
vated human AB serum and phytohemagglutinin-P for 72 hours. Colcemid (0.02 p,g/ 
ml) was added 2 hours prior to harvesting. Air-dried chromosome preparations 
were made by a conventional method. Ag-NOR staining was performed according 
to Howell  and Black's method [17]. The amount of Ag-stain on each acrocentric 
chromosome was recorded visually as 0 (absent), 1 (small), 2 (medium), or 3 (large), 
according to Mil ler et al. [18]. Ten metaphases from each subject were scored for 
positive silver staining of NORs. 
RESULTS 
Individual variations in modal numbers of Ag-NORs were observed in the precan- 
cerous and cancerous group, as well  as in controls (Table 1). The modal numbers 
varied from 5 to 10 (controls) and 4 to 10 (precancerous lesions) whereas, in cancer 
patients, the modal number was between 5 and 8.5. The variation of Ag-NORs in 
cancer cases was lower, and compared with that of normal and precancerous lesion 
subjects. The average modal  number of Ag-NORs was found to be less in cancer 
cases (6.38), compared with that of controls {7.00}. The average Ag-NOR per meta- 
phase was found to be less {6.25 _+ 0.88} in the cancer group compared with con- 
trols (7.03 +- 0.88). The difference was found to be statistically significant (p < 
0.02}. The modal number of Ag-NORs in cases with precancerous lesions was 7.0, 
7.3, and 6.1 in mild, moderate, and severe dysplasias, respectively. Although there 
was an apparent decrease in the frequency of Ag-NORs in severe dysplastic ases 
{6.23 - 1.09}, the difference was not significant (p > 0.05), compared with those of 
cases with mild (7.13 ± 1.21) and moderate (7.23 ± 1.18} dysplasias. Ag-NORs in 
the precancerous group, as a whole, did not differ from that of controls. 
The distribution of Ag-NORs was further analyzed to look into variations with 
respect o D and G group chromosomes. Analysis revealed that the decreased fre- 
quency of Ag-NORs in cancer cases was not due to any specific group of chromo- 
somes {D and G), but was evident in both groups (Table 1}. The distr ibution of the 
modal number of Ag-NORs among the groups is shown in Table 2. The majority of 
cases of severe dysplasia (87.50%} and cancer (93.75%) revealed modal  numbers 7 
or less, compared with normal women (56.75%} and other lower grades of dyspla- 
Table 1 Frequency of Ag-NORs in different groups of women 
Silver stained NORs 
Number 
Group studied Modal number Mean ± SD/metaphase D group G group 
Controls 37 7.0 (5-10) 7.03 ± 0.88 4.16 ± 0.76 2.87 ± 0.70 
Dysplasias 
Mild 23 7.0 (4-10) 7.13 ± 1,21 4.39 ± 0.74 2.65 ± 0.78 
Moderate 22 7.3 (5-10) 7.23 ± 1.18 4.38 ± 0.91 2.85 ± 0.86 
Severe 8 6.1 (4-8) 6.23 ± 1.10 3.90 -- 1.09 2.33 ± 0.49 b 
Cancer 18 6.3 (5-8.5) 6.25 ± 0.88 ° 3.77 -- 0.78 2.48 ± 0.63 
°Significant in t test: p < 0.02. 
bSignificant in t test: p > 0.05. 
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Table ~. Distribution of Ag-NORs in different groups of women 
Number 
Group studied 6 
Modal number of Ag-NORs 
7 8 9 10 
Controls 37 9 (24.32)" 12 (32.43) 13 (35.13) 1 (2.70) 
Dysplasia 
Mild 23 5 (21.74) 8 (34.78) 7 (30.43) 2 (8.69) 
Moderate 22 5 (22.73) 7 (31.82) 7 (31.82) 1 (4.55) 
Severe 8 5 (62.50) 2 (25.00) 1 (12.50) - -  




°Numbers in parenthesis indicate percentage. 
Table 3 Amount of Ag stain per acrocentric hromosome in different groups of 
individuals 
Ag stain per chromosome Ag stain per 
Number of acrocentric 
Group individuals D group G group chromosome (D + G} 
Controls 37 1.0388 1.1308 1.0555 
Dysplasia 
Mild 23 1.3061 1,1578 1.2468 
Moderate 22 1.0089 0,9178 0.9725 
Severe 8 0.8816 0,7895 0.8447 
Cancer 16 0.8570 0.8602 0.8583 
sias (Table 2). Rarely, an indiv idual  with cancer had modal numbers 8 or more 
(6.25%}, compared with controls {40.74%}. Further, none of the groups showed any 
age relationship with Ag-NORs by regression analysis. 
The results on the amount of Ag stain per acrocentric hromosome are shown in 
Table 3. The data revealed an apparent decreasing trend in the amount of Ag stain 
from controls to cancer, except in mild dysplasia cases. The decrease in the amount 
of Ag stain per acrocentric hromosome in cancer and severe dysplasia cases was 
almost similar. The data from both mean NOR value and amount of Ag stain per 
chromosome indicated decreased activity of rDNA regions in both cancer and se- 
vere dysplasia cases, in comparison with controls and mild-to-moderate dysplasia 
cases. 
DISCUSSION 
Our results indicate a decrease in the frequency of Ag-NORs in cancer cases, in 
comparison with controls. The data also revealed an apparent decrease of Ag-NORs 
in severe dysplasia cases when compared with controls. The trend of decrease in 
the frequency of Ag-NORs in cancer and severe dysplasia cases is interesting, be- 
cause the progression rate of this severe grade of precancerous lesion to cancer was 
reported to be significantly more in comparison with milder forms of precancerous 
groups [20-23]. 
The cl inical significance of Ag-NOR activity is not known; however, there have 
been several reports on the decrease of Ag-NORs in leukemia and lymphoma [11- 
14]. A significant decrease of Ag-NORs was also reported in a case of CML in blastic 
crisis [24]. Excluding the report by Cheng at al. [15], no data are available thus far 
on the increase of Ag-NOR frequency in patients with adenocarcinoma. Recently, 
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Schulze et al. [14] found no detectable increase in the number of active NORs in 
cells of patients with malignant disease. However, a remarkably low NOR activity 
was observed in infectious mononucleosis. Evidence also showed that tumor cells 
release certain factors that had varied effects on circulating lymphocytes [18]. 
Some unknown serum factor may be responsible for suppressive action on rDNA 
transcription. However, the relation of rDNA activity and Ag-NOR is not clear, since 
inhibit ion of RNA synthesis by actinomycin D did not give consistent results [25]. 
Our analysis of the amount of Ag stain also revealed a decreased value per ac- 
rocentric chromosome in cancer (0.85} and severe dysplasia cases (0.84), in com- 
parison with controls (1.05}. It is l ikely that this variation in the amount of Ag stain 
is due to difference in the amount of rDNA, because hybridization in situ [26, 27] 
and filter hybridizat ion [28] demonstrated that acrocentric hromosomes differ in 
the number of copies of rRNA genes they carry. In view of the nature of Ag stained 
material at the NOR [29], however, it is l ikely that this may not account for all the 
variations of Ag stain we have seen in our material. 
In our analysis, the data did not show any age relationship with the frequency 
of Ag-NORs, as was reported by an earlier study on normal individuals [30]. The 
reasons for such difference in observation is not clear. Further comment on age 
relationship of Ag-NOR from this study may not be possible, since we do not have 
individuals of all age groups, especial ly patients younger than age 20. 
In view of the variable biologic behavior of the dysplastic lesions of the uterine 
cervix, the observation of reduced activity of Ag-NOR in both cancer and severe 
dysplasia cases seems to be significant. Various prospective studies have demon- 
strated higher progression rates for severe dysplasia cases, compared with other 
milder groups of dysplasia. The decrease of Ag-NOR in severe dysplasia indicates 
the possibi l i ty that this phenomenon may have some impl icat ion in relation to the 
development of malignancy. The exact relation of the activity of r ibosomal genes 
with malignancy is not known. The question regarding the expression of Ag-NORs 
and the development of malignancy appears to be of interest. 
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